Changes in cardiopulmonary exercise capacity and limitations 3-12 months after COVID-19

Charlotte Björk Ingul1,2,3, Anne Edvardsen1,4, Turid Follestad5

  • 1LHL Hospital Gardermoen, Jessheim, Norway.

Insights

One year after COVID-19 hospitalization, most patients regain normal exercise capacity, though some experience persistent intolerance. Cardiopulmonary function, including peak oxygen uptake, significantly improves from 3 to 12 months post-discharge.

Area of Science:

  • Cardiology
  • Pulmonology
  • Exercise Physiology

Background:

  • Coronavirus disease 2019 (COVID-19) can lead to prolonged cardiopulmonary dysfunction.
  • Understanding long-term exercise capacity after COVID-19 hospitalization is crucial for patient recovery and rehabilitation.

Purpose of the Study:

  • To evaluate cardiopulmonary function 12 months post-hospital discharge for COVID-19.
  • To assess changes in exercise capacity from 3 to 12 months after discharge.
  • To compare exercise parameters in COVID-19 survivors with matched controls without COVID-19.

Main Methods:

  • A prospective, longitudinal, multicentre cohort study involving hospitalized COVID-19 patients.
  • Cardiopulmonary exercise testing (CPET) performed at 3 and 12 months post-discharge.
  • Comparison with a control group matched for age, sex, BMI, and comorbidities.

Main Results:

  • At 12 months, 77% of COVID-19 patients had normal exercise capacity, while 23% showed exercise intolerance.
  • Circulatory factors were more prevalent than ventilatory factors in patients with exercise intolerance.
  • Significant improvements in peak oxygen uptake (VO2peak) and oxygen pulse were observed between 3 and 12 months post-discharge.

Conclusions:

  • The majority of COVID-19 survivors achieve normal exercise capacity one year after hospitalization.
  • Exercise intolerance, often linked to circulatory limitations and deconditioning, persists in a minority of patients.
  • Cardiopulmonary function demonstrates significant recovery from 3 to 12 months post-discharge.
Abstract

Related Concept Videos

Respiratory Capacities01:24

Respiratory Capacities

Respiratory capacities are crucial indicators of lung function, representing the maximum amount of air an individual's respiratory system can handle during various breathing phases.
One key metric is the Inspiratory Capacity (IC), which represents the maximum amount of air that can be inhaled with full effort. IC is calculated by summing the tidal volume and inspiratory reserve volume, typically ranging from 2.4 to 3.6 liters.
The Functional Residual Capacity (FRC) represents the air in the...
876
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
51.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
463